
Global Cytology Educational Program
The ASC’s Global Cytology Educational Program will expand cytopathology skills to all pathology professionals internationally, allowing them to adapt to this ever-changing industry.
Pathologists and pathology trainees from around the world will have an opportunity to participate in this unique program that provides global access to cytopathology education from skilled faculty in the United States.
The Global Cytology Educational Program will cover the current cytopathology topics with:
- Wide-ranging and customized educational sessions to enhance diagnostic techniques
- Multimodal learning, including pre-workshop self learning, engaging and interactive live virtual educational strategies, and scored self assessments
- A dynamic, world-renowned faculty currently practicing in the United States
- Opportunity for Q&A and ability to share experiences from different cytopathology practice settings
Subspecialty education in cytopathology is limited globally. This certificate program will provide opportunities for exposure to and education in cytopathology. The virtual format will enable participation from different regions of the world, including resource limited settings.
The ASC’s Global Cytology Educational Program will expand cytopathology skills to all pathology professionals internationally, allowing them to adapt to this ever-changing industry.
Pathologists and pathology trainees from around the world will have an opportunity to participate in this unique program that provides global access to cytopathology education from skilled faculty in the United States.
LIVE PRESENTATIONS
Date | Time | Presenter | Topic | |
August 10, 2022 | 10:30 AM, Eastern | 2:30 PM, GMT | Barbara Centeno, MD | Pancreas Cytopathology |
October 12, 2022 | 10:30 AM Eastern | 2:30 PM, GMT | Christopher Griffith, MD, PhD | Head & Neck Cytopathology |
December 14, 2022 | 10:30 AM Eastern | 2:30 PM, GMT | Marilin Rosa, MD | Breast Cytopathology |
February 8, 2023 | 10:30 AM Eastern | 2:30 PM, GMT | Liron Pantanowitz, MD | Soft Tissue Pathology |
April 12, 2023 | 10:30 AM Eastern | 2:30 PM, GMT | Krisztina Hanley, MD | GYN Pathology |
June 14, 2023 | 10:30 AM Eastern | 2:30 PM, GMT | Daniel Lubin, MD | Salivary Gland Cytopathology |
Target Audience
Cytologists/cytotechnologists, cytology/cytotechnology students, pathologists, cytopathologists, pathology residents and fellows from the international community.
Learning Objectives
- Expose learners to the basics cytology of commonly sampled specimens
- Discuss common entities, morphologic pitfalls, and applicable ancillary tests
- Highlight the value of rapid on site evaluation (ROSE) and discuss appropriate triaging
- Review standardized classification systems and general cytopathology reporting
- Model fine needle aspiration (FNA) and slide preparation techniques
- Expose learners to the basics cytology of commonly sampled specimens
- Discuss common entities, morphologic pitfalls, and applicable ancillary tests
- Highlight the value of rapid on site evaluation (ROSE) and discuss appropriate triaging
- Review standardized classification systems and general cytopathology reporting
- Model fine needle aspiration (FNA) and slide preparation techniques
Diversity, Equity and Inclusion Committee
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.
The following individuals have reported financial relationships:
Oscar Lin MD PhD: Consultant – Hologic and Jansen
Liron Pantanowitz MD: Consultant – Hamamatsu, Advisory Board for Ibex
Martha B Pitman MD FIAC: Consultant – Adenocyte, LLC
Donna K. Russell MEd CT(ASCP) HT(ASCP): Advisory Board – Hologic Scientific
Christopher J. VandenBussche MD PhD: Ad hoc advisory board panel and Consultant – Roche
The following individuals have reported no relevant financial relationships:
Susan A. Alperstein, MS, CT(ASCP), Fatima Z. Aly, MD, PhD, Tatjana Antic, MD, Kristen A. Atkins, MD, Guliz A. Barkan, MD, Christine N. Booth, MD, Barbara A. Centeno, MD, Aastha Chauhan, MD, Jeanine M. Chiaffarano, DO, Paul Z. Chiou, MPH, SCT(ASCP), Deborah J. Chute, MD, Amy C. Clayton, MD, Jacqueline M. Cuda, BS, SCT(ASCP), Kara L. Hansing, MEd, SCT(ASCP)CM, Melissa Hogan, MD, Seema Khutti, MBBS, Xiaoqi Lin, MD, PhD, Patrick McIntire, MD, Sanjana Mehrotra, MD, Sara E. Monaco, MD, Seyedreza Mousavi, MD, MS, Ranjana S. Nawgiri, MD, M. Katayoon Rezaei, MD, Esther D. Rossi, MD, PhD, Sinchita Roy-Chowdhuri, MD, PhD, Sadia Sayeed, MD, Momin T. Siddiqui, MD, FIAC, Swikrity Upadhyay Baskota, MD, Saloni Walia, MD
The ASC staff associated with the development of content for this activity reported no relevant financial relationships.
Presenters: The presenters have no conflicts of interest or financial relationships to disclose.
Participants who view attend all sessions and complete the pre- and post-session surveys will receive a certificate of participation after the end of the course in June 2023. Sponsored by the Diversity, Equity, and Inclusion Committee of the American Society of Cytopathology (ASC).
Available Credit
- 2.00 Participant